Cargando…
DNA methylation may mediate psychotropic drug-induced metabolic side effects: results from a 1-month observational study
INTRODUCTION: Metabolic side effects of psychotropic medications are a major drawback to patients’ effective treatment. Among the mechanisms underlying their development, DNA methylation may be involved. OBJECTIVES: The aim of this study was to estimate DNA methylation changes occurring secondary to...
Autores principales: | Dubath, C., Porcu, E., Delacrétaz, A., Grosu, C., Laaboub, N., Piras, M., Von Gunten, A., Conus, P., Von Plessen, K., Kutalik, Z., Eap, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567522/ http://dx.doi.org/10.1192/j.eurpsy.2022.285 |
Ejemplares similares
-
Effects of psychotropic switches on weight change: a prospective cohort study
por: Piras, M., et al.
Publicado: (2022) -
Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysis
por: Sjaarda, Jennifer, et al.
Publicado: (2023) -
Metabolic disturbances are associated with psychiatric readmission: results from a Swiss psychiatric cohort
por: Laaboub, N., et al.
Publicado: (2022) -
Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort
por: Laaboub, Nermine, et al.
Publicado: (2022) -
Publisher Correction: Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort
por: Laaboub, Nermine, et al.
Publicado: (2022)